These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 709290)

  • 21. Drug-drug interactions with fluoroquinolones.
    Marchbanks CR
    Pharmacotherapy; 1993; 13(2 Pt 2):23S-28S. PubMed ID: 8474934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A model solution for intestinal absorption of warfarin. A drug with non-linear distribution pharmacokinetics in the rat.
    Julkunen RJ; Kekki M; Wahlström B
    Arzneimittelforschung; 1980; 30(2):264-7. PubMed ID: 7378103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of food and of antacid on the single oral dose pharmacokinetics of tenoxicam.
    Francis RJ; Dixon JS; Lowe JR; Harris PA
    Eur J Drug Metab Pharmacokinet; 1985; 10(4):309-14. PubMed ID: 3879481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of composition on the neutralizing properties of antacid preparations.
    Pawlaczyk J; Lutka A; Kokot Z
    Pharmazie; 1984 May; 39(5):334-6. PubMed ID: 6473495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Interactions between anti-arrhythmic agents, antacids and antidiarrheals. IV. Procainamide and propranolol: adsorption on antacids and antidiarrheals and the effect of these latter on in vitro absorption].
    Remon JP; Van Severen R; Braeckman P
    Pharm Acta Helv; 1981; 56(9-10):257-61. PubMed ID: 7291209
    [No Abstract]   [Full Text] [Related]  

  • 26. [Caution with methylxanthines, antacids or warfarin! Drug interactions with quinolones].
    Jetter A; Fuhr U
    Pharm Unserer Zeit; 2001; 30(5):429-34. PubMed ID: 11575180
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of food, an antacid, and the H2 antagonist ranitidine on the absorption of BAY 59-7939 (rivaroxaban), an oral, direct factor Xa inhibitor, in healthy subjects.
    Kubitza D; Becka M; Zuehlsdorf M; Mueck W
    J Clin Pharmacol; 2006 May; 46(5):549-58. PubMed ID: 16638738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicompartment analysis of the absorption kinetics of warfarin from the stomach and small intestine.
    Kekki M; Pyörälä K; Mustala O; Salmi H; Jussila J; Siurala M
    Int Z Klin Pharmakol Ther Toxikol; 1971 Oct; 5(2):209-11. PubMed ID: 5134637
    [No Abstract]   [Full Text] [Related]  

  • 29. Warfarin absorption after massive small bowel resection.
    Lutomski DM; LaFrance RJ; Bower RH; Fischer JE
    Am J Gastroenterol; 1985 Feb; 80(2):99-102. PubMed ID: 3970008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse antibiotic drug interactions.
    Bint AJ; Burtt I
    Drugs; 1980 Jul; 20(1):57-68. PubMed ID: 6995091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of liver cytochrome P450s by Danshen-Gegen formula is the leading cause for its pharmacokinetic interactions with warfarin.
    Zhang Z; Ge B; Zhou L; Lam TN; Zuo Z
    J Ethnopharmacol; 2014 Jul; 154(3):672-86. PubMed ID: 24832110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug interactions with antacids. Mechanisms and clinical significance.
    Sadowski DC
    Drug Saf; 1994 Dec; 11(6):395-407. PubMed ID: 7727050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug interactions and lethal drug combinations.
    Richens A
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():94-8. PubMed ID: 60351
    [No Abstract]   [Full Text] [Related]  

  • 34. Warfarin absorption in a patient with short-bowel syndrome.
    Lehman ME; Kolb KW; Barnhart GR; Wagman LD; Barr WH
    Clin Pharm; 1985; 4(3):325-6. PubMed ID: 4006397
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical pharmacokinetics of oral anticoagulants.
    Kelly JG; O'Malley K
    Clin Pharmacokinet; 1979; 4(1):1-15. PubMed ID: 369763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of clofibrate with warfarin. I. Effect of clofibrate on the disposition of the optical enantiomorphs of warfarin.
    Bjornsson TD; Meffin PJ; Blaschke TF
    J Pharmacokinet Biopharm; 1977 Oct; 5(5):495-505. PubMed ID: 925883
    [No Abstract]   [Full Text] [Related]  

  • 37. Bioavailability of warfarin in a patient with severe short bowel syndrome.
    Kearns PJ; O'Reilly RA
    JPEN J Parenter Enteral Nutr; 1986; 10(1):100-1. PubMed ID: 3945042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In vitro evaluation of antacid activity in gastric acid secretion in static and dynamic systems].
    Vatier J; Malikova-Sekera E; Vitre MT; Mignon M
    Therapie; 1992; 47(2):99-104. PubMed ID: 1412150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of small doses of aluminum-containing antacids on calcium and phosphorus metabolism.
    Spencer H; Kramer L; Norris C; Osis D
    Am J Clin Nutr; 1982 Jul; 36(1):32-40. PubMed ID: 7091034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Warfarin resistance in a patient with short bowel syndrome.
    Brophy DF; Ford SL; Crouch MA
    Pharmacotherapy; 1998; 18(3):646-9. PubMed ID: 9620117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.